Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GSK 3965193

Next Previous
X
Search
Drug Profile

GSK 3965193

Alternative Names: GSK-3965193

Latest Information Update: 05 Sep 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlaxoSmithKline
  • Developer GSK
  • Class Antivirals
  • Mechanism of Action TENT4A protein inhibitors; TENT4B protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Hepatitis B

Most Recent Events

  • 22 Jun 2022 Pharmacodynamics data from a preclinical trial in chronic hepatitis B presented at the International Liver Congress (ILC-2022)
  • 15 Apr 2022 Preclinical trials in Hepatitis B in United Kingdom (unspecified route) prior to April 2022
  • 14 Apr 2022 Phase-I/II clinical trials in Hepatitis B (Combination therapy) in United Kingdom (NCT05330455)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top